In oesophageal cancer, neoadjuvant chemotherapy activated T cells, including Tfh cells, which stimulate CD40 on B cells to promote their activation and anti‐tumour effects via NF‐κB signalling and antigen presentation.31 This evidence concerns the gene NFKB1 and neoplasm.